Lipitor and Vyepti drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lipitor (atorvastatin calcium) and Vyepti (eptinezumab-jjmr). Common drug interactions include headache among females and balance disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Lipitor and Vyepti. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,047 Lipitor users. Check the latest studies of Lipitor.

What is Vyepti?

Vyepti has active ingredients of eptinezumab-jjmr. eHealthMe is studying from 4,897 Vyepti users. Check the latest studies of Vyepti.

On Jul, 19, 2026

14 people who take Lipitor and Vyepti together, and have interactions are studied.

What are the common drug interactions of Lipitor and Vyepti, by gender? *:

female:

Headache (pain in head)
Drug ineffective
Constipation
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Dry mouth
Stomatitis (inflammation of mucous membrane of mouth)
Type iv hypersensitivity reaction (delayed type hypersensitivity as the reaction takes two to three days to develop)
Cardiac flutter (abnormal heart rhythm)
Chest pain
Dizziness

male:

Balance disorder
Dizziness
Confusional state
Delirium (wild excitement)
Pneumonia
Drug hypersensitivity
Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
Nausea (feeling of having an urge to vomit)
Therapeutic response decreased (less preventive response)
Tremor (trembling or shaking movements in one or more parts of your body)

What are the common drug interactions of Lipitor and Vyepti, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Type iv hypersensitivity reaction (delayed type hypersensitivity as the reaction takes two to three days to develop)
Chest pain
Dizziness
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Migraine (headache)
Nausea (feeling of having an urge to vomit)

40-49:

n/a

50-59:

Constipation
Headache (pain in head)
Hospitalisation
Neoplasm (tumour)

60+:

Balance disorder
Dizziness
Dry mouth
Headache (pain in head)
Stomatitis (inflammation of mucous membrane of mouth)
Acute myocardial infarction (acute heart attack)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cardiac flutter (abnormal heart rhythm)
Confusional state
Delirium (wild excitement)

What are the existing conditions these people have? *

Migraine (headache): 13 people, 92.86%
Nausea (feeling of having an urge to vomit): 3 people, 21.43%
Headache (pain in head): 3 people, 21.43%
Status Migrainosus (a migraine headache for 72 hours): 2 people, 14.29%
Migraine Without Aura (headache without neurological problems): 2 people, 14.29%
Weight Decreased: 1 person, 7.14%
Sleep Disorder: 1 person, 7.14%
Secondary Immunodeficiency (lack of immunity due to some disease): 1 person, 7.14%
Primary Immunodeficiency Syndrome: 1 person, 7.14%
Muscle Spasms (muscle contraction): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Lipitor and Vyepti?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously